Business executives from startups and growth-stage companies can network and share information at The North Carolina Nanotechnology Commercialization Conference’s Nanomedicine Commercialization Workshop on strategies for company building and moving to market.

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here’s the best of what YOU had to say:

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here’s the best of what YOU had to say:

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts. Now here’s the best of what YOU had to say:

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: A handful of investment firms are interested in Brea, California, company Beckman Coulter, and the top 10 IT implications of healthcare reform.

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week: top IT implications of healthcare reform and could FDA staffers be fired because they’re smarter than the boss?

Many medical technologies never realize their full potential because the factors that limit broad adoption are not fully understood and addressed. This is why many technologies realize no more than 15-20% of their true potential, despite massive investments and nearly heroic efforts of the sales, marketing and leadership teams.

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. This week:

The Ohio Venture Association will focus on the world of biomedical technology when Frank Douglas, President and CEO of the Akron BioInnovation Institute, speaks at its upcoming lunch meeting.

One of the biggest issues today in medical technology is not regulatory, or reimbursement, or the burden of clinical evidence; it is the lack of a sufficiently clear understanding of the market and market dynamics.